We interview hematologist Neal Weinreb, MD, director of the University Research Foundation for Lysosomal Storage Diseases and a researcher involved in studying Gaucher disease for more than 3 decades. Dr Weinreb talks about the risks of cancer in patients with type 1 Gaucher disease and why hematologists and oncologists need to know about this rare inherited disorder.
At the Third Annual Interdisciplinary Prostate Cancer Congress in March, the audience viewed presentations of real prostate cancer cases treated by the speakers. How would you treat the patient in this case study? Compare your responses with those of the attendees and the expert panel.
Three presentations at the recent Third Annual Interdisciplinary Prostate Cancer Congress in New York are reviewed. Urologist Leonard Gomella, MD, addresses truths and myths about prostate cancer prevention;Daniel P. Petrylak, MD, discusses the timely topic of immunotherapy; and E. David Crawford, MD, talks about screening controversies.
Healthcare professionals and patients are facing a longer wait for the FDA to approve generic drugs than they were just 5 years ago--1 year longer, in fact. The delayed approval process is due to a growing backlog of applications at the FDA.
In data presented at the 2nd European Lung Cancer Conference, a team of investigators said adding ifosfamide to a combination regimen of cisplatin plus etoposide demonstrated strong activity and tolerability in patients with small cell lung cancer (SCLC).
Being able to predict which women diagnosed with ductal carcinoma in situ (DCIS) are likely to develop subsequent invasive breast cancer could prevent a lot of unnecessary treatment, said researchers from the University of California San Francisco (UCSF).
Kantar Health Research recently conducted an Internet survey of approximately 250 oncologists from the United States, France, Germany, Italy,Spain, and the United Kingdom. Using a proprietary scoring system Kantar Health calls the TRI*M Index, the research firm assessed relationships between physicians and pharmaceutical company representatives.
The American Society of Clinical Oncology (ASCO)and the College of American Pathologists (CAP) jointly released guidelines designed to improve the accuracy and usefulness of immunohistochemical (IHC) testing for estrogen receptor (ER) and progesterone receptor (PgR) status in breast cancer tumors after convening a panel of international experts to study the issue.
Oncology & Biotech News is now united with the experienced publishing, editorial, and creative staff of Oncology Net Guide and OncLive Nursing under the Oncology Specialty Group umbrella, which also includes our newest publication, Contemporary Oncology.
June-December Calender
Notable sessions and events
Three hot Gadgets
In a presentation at the Third Annual Interdisciplinary Prostate Cancer Congress (IPCC), Howard M. Sandler, MD, MS, a Ronald H. Bloom Family Chair in Cancer Therapeutics and professor and chair of the Department of Radiation Oncology at Cedars Sinai Medical Center in Los Angeles,
According to the Centers for Disease Control and Prevention, colorectal cancer is the second leading cancer killer in the United States, affecting both men and women.
"In most cancer centers, and in good community practices, we do a pretty good job at the time of diagnosis informing a patient and their family what the diagnosis is, and what they'll need to do to get through treatment," Ganz says. "But patients often have no idea what to expect once they've finished their cancer treatment, and neither do the primary care providers on their t
Proton therapy centers are being built around the country, and one of the companies leading this effort is ProCure, a company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. Since 2005, ProCure has developed several centers and more are underway.
Radiation therapy has been used to treat cancer for more than 100 years, and was made possible by the discovery of X-rays in 1895 by German physicist Wilhelm Conrad Röntgen, which allowed tumors to be detected more easily and noninvasively.
The Ovarian Cancer National Alliance states that approximately 20,000 American women receive an ovarian cancer diagnosis annually, with about 15,000 dying of the disease.
Electronic communication technologies have radically changed our world, transforming almost every aspect of our daily lives. Most of the tasks we need to perform can be handled electronically, from paying bills and shopping to communicating with friends and family.
Traditionally, physicians have relied on textbooks, conferences, and, more recently, the Internet to keep abreast of the latest clinical data and support clinical decision-making
In 1890, Louise Brandeis and Samuel Warren published �¢ï¿½ï¿½The Right to Privacy�¢ï¿½ï¿½ in the Harvard Law Review, indicating private individuals were being injured by the invasions of modern-day technology
Three hot gadgets for Oncologists.
In October 2000, a team of researchers at Stanford University led by Vijay Pande, PhD, debuted a distributed computing project designed to simulate the protein folding process.
